First human trial tests cord stem cells against rare Muscle-Wasting disease
NCT ID NCT07086521
Summary
This early-stage study is testing whether stem cells from umbilical cord linings are safe and might help people with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that weakens muscles. Sixteen participants with moderate FSHD will receive four IV infusions over nine months—two containing the stem cell product and two containing a placebo saline solution—to compare effects. Researchers will primarily monitor for safety issues while also checking if the treatment improves muscle function, reduces pain, or enhances quality of life over a 21-month period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford Neuroscience Health Center
RECRUITINGPalo Alto, California, 94304, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.